Zhejiang Shengda Bio-Pharm Co., Ltd.
603079.SS
Get informed when a big investor buys or sells
+ FollowMarket Cap$2.52B
Close$
$13.42
3.9% upside
Current Fair Value
3.9% upsideUndervalued by 3.9% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $2.52 Billion |
|---|---|
| Enterprise Value | $2.41 Billion |
| Dividend Yield | $0.10 (0.75%) |
| Earnings per Share | $0.35 |
| Beta | 0.33 |
| Outstanding Shares | 187,437,124 |
Return
| Return on Equity | 2.83% |
|---|---|
| Return on Assets | 1.98% |
| Return on Invested Capital | 1.12% |
Valuation & Multiples
| P/E Ratio | 55.37 |
|---|---|
| PEG | -101.93 |
| Price to Sales | 3.23 |
| Price to Book Ratio | 1.62 |
| Enterprise Value to Revenue | 2.9 |
| Enterprise Value to EBIT | 109.67 |
| Enterprise Value to Net Income | 53 |
| Total Debt to Enterprise | 0.18 |
| Debt to Equity | 0.28 |
Revenue Sources
No data
Insider Trades
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Zhejiang Shengda Bio-Pharm Co., Ltd.
1,083 employees
CEO: Chao Liang Zhejiang Shengda Bio-Pharm Co., Ltd., based in Tiantai, China, is a global enterprise dedicated to the research, development, manufacturing, and distribution of a diverse range of food and animal feed additives. The company's comprehensi...